Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 24/05/21

Trade details

Type
Insider sale
Amount
$405.75
Shares · price
541 sh · $0.75 a share
Held after
75,481 sh
Trade date
24/05/17
Filed
24/05/21
Days to filing
4 days

Sold 0.7% of holdings

Share of holding sold
0.7%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/17~24/06/16

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $8,136

    Filed 25/03/27

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24